Safety and Tolerability of GTX-104 Compared with Oral Nimodipine in Patients with ASAH
Clinical trial NCT05995405 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05995405
- Sponsor
- Grace Therapeutics Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-20
- Primary completion
- 2024-12-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.